# WuXi Biologics to build €325M biologics facility in Dundalk, Ireland

WuXi Biologics will invest €325 million to build a new biologics drug substance manufacturing facility in Dundalk, Ireland, creating 400 jobs over five years. The facility will use single-use bioreactors and is the company's first site outside China.

- Type: New facility
- Announced: 2018-04-30
- Where: Dundalk, Co. Louth, Ireland
- Value: $395.0M (325.0M EUR)
- Jobs: 400
- Status: announced
- Capacity: 48,000 L fed-batch and 6,000 L perfusion bioreactor capacity
- Products: biologics drug substances
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [WuXi Biologics](https://endata.com/companies/31607.md)

## Sources

- [wuxibiologics.com](https://www.wuxibiologics.com/wuxi-biologics-to-invest-e325-million-to-build-largest-biomanufacturing-facility-using-single-use-bioreactors-in-ireland/), 2018-04-30: "WuXi Biologics is to invest €325 million and create 400 new jobs over five years in a new biologics drug substance manufacturing facility on the Industrial Development Authority’s (IDA) greenfield site in Mullagharlin, Dundalk, Co. Louth."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.